戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 hole-brain radiotherapy improves survival in primary central nervous system lymphoma.
2 be studied for newly diagnosed and recurrent primary central nervous system lymphoma.
3 cular disease or as secondary involvement by primary central nervous system lymphoma.
4 inetics to water- and lipid-soluble drugs in primary central nervous system lymphomas.
5 h the acquired immunodeficiency syndrome and primary central nervous system lymphoma (AIDS-PCNSL) is
6 agnosis of primary vitreoretinal lymphoma or primary central nervous system lymphoma and can regress
7 , particularly for responsive tumors such as primary central nervous system lymphoma and oligodendrog
8 ly among individuals with low-grade gliomas, primary central nervous system lymphoma and those underg
9  lymphoma, 5 (9%) Burkitt lymphoma, 10 (18%) primary central nervous system lymphoma, and 7 (13%) oth
10 n spinal fluid is useful in the diagnosis of primary central nervous system lymphoma, and monitoring
11                               Most trials of primary central nervous system lymphoma are employing sy
12  induced frequent responses in patients with primary central nervous system lymphoma but was associat
13                            The International Primary Central Nervous System Lymphoma Collaborative Gr
14 ients with uncommon histological variants of primary central nervous system lymphoma have been publis
15 e cerebrospinal fluid (CSF) in patients with primary central nervous system lymphoma; however, the CS
16  intraocular lymphoma (PIOL) is a variant of primary central nervous system lymphoma in which lymphom
17 best mode for treatment of PIOL or recurrent primary central nervous system lymphoma involving only t
18                                              Primary central nervous system lymphoma is a rare form o
19 Salvage therapy for progressive or recurrent primary central nervous system lymphoma is an area of ac
20                             The incidence of primary central nervous system lymphomas is increased se
21                                              Primary central nervous system lymphoma (PCNSL) in HIV p
22                                              Primary central nervous system lymphoma (PCNSL) is a rar
23                                              Primary central nervous system lymphoma (PCNSL) is an ag
24                         Visual impairment in primary central nervous system lymphoma (PCNSL) is cause
25                                              Primary central nervous system lymphoma (PCNSL) represen
26                                              Primary central nervous system lymphoma (PCNSL) risk is
27                                              Primary central nervous system lymphoma (PCNSL) that ari
28                                              Primary central nervous system lymphoma (PCNSL) treatmen
29 se 2 study for patients with newly diagnosed primary central nervous system lymphoma (PCNSL) using in
30 chemotherapy is the mainstay of treatment of primary central nervous system lymphoma (PCNSL), but rel
31 vances in the understanding and treatment of primary central nervous system lymphoma (PCNSL).
32 opsy prevents histopathological diagnosis of primary central nervous system lymphoma (PCNSL).
33                                              Primary central nervous system lymphomas (PCNSLs) and pr
34                                              Primary Central Nervous System Lymphomas (PCNSLs) are ra
35 affecting the brain (cerebral toxoplasmosis, primary central nervous system lymphoma, progressive mul
36           However, the optimal management of primary central nervous system lymphoma remains to be de
37           In 2005, the optimal treatment for primary central nervous system lymphoma remains undefine
38   Future studies on the biology of recurrent primary central nervous system lymphoma should help to c
39 t progress has been made in the treatment of primary central nervous system lymphoma since the time w
40  To evaluate whether the chemosensitivity of primary central nervous system lymphomas to water-solubl
41 sis of primary vitreoretinal lymphoma and/or primary central nervous system lymphoma was made within
42 d with primary vitreoretinal lymphoma and/or primary central nervous system lymphoma were analyzed.
43  AIDS-primary effusion lymphoma; 1 of 4 AIDS-primary central nervous system lymphoma), with 9 of 39 (
44 e neurocognitive deficits among survivors of primary central nervous system lymphoma without residual

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。